Clinical Trial Information

A Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects with Severe Community-Acquired Pneumonia (sCAP)

Protocol Number: 16039
Status: Open
Age Group: Adult
Treatment Type: Treatment
Secondary Protocol No.: BIOTEST 996
Phase: III
NCT ID: NCT05722938

Scope Information

Scope:: National
Disease Site(s):: Other